~~<i id='9EA7E80075'><strike id='9EA7E80075'><tt id='9EA7E80075'><pre id='9EA7E80075'></pre></tt></strike></i>~~

Home» knowledge» leisure time

leisure time

author：comprehensive 2025-10-01 02:17:42 Page View：17

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Abortion pill Supreme Court ruling could impact entire drug industry
Next article： Alkermes shareholders re

focus

Trump demands the U.S. pay no more for drugs than other countries … again

EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

Readout Newsletter: Merck, Vertex, and Viking updates

MelEvans/APNewbiotechnewsletterlaunchingthisThursday. Don’tmissout.Hello,everyone.Damianherewithaloo

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

UnitedHealth increases loan offers after Change Healthcare outage

JimMone/APUnitedHealthGroupappearstobeofferingsomeprovidersmoresubstantialloansinthewakeofthecyberat